As of 4/10/2026, 11:49:47 AM
Market Cap
86.96B
P/E Ratio (TTM)
13.64
Free Float
-
Volume (30D Avg)
75.07K
1Y Change
-6.61%
Shares Outstanding
117.05M
| Period | Revenue | Profit After Tax | EPS |
|---|---|---|---|
| 2025 | 43.11M | 6.37M | 54.45 |
| 2024 | 37.21M | 4.58M | 39.11 |
| 2023 | 31.61M | 995,586 | 8.51 |
| 2022 | 27.51M | 325,411 | 2.78 |
| Ex-Date | Amount | Yield (%) |
|---|---|---|
| Apr 21, 2026 | Rs. 15.00 | - |
| Nov 04, 2025 | Rs. 5.00 | - |
| Sep 02, 2025 | Rs. 10.00 | 3.48% |
| Mar 11, 2025 | Rs. 15.00 | 2.52% |
| Nov 05, 2024 | Rs. 5.00 | 0.77% |
| Apr 15, 2021 | Rs. 5.00 | 2.28% |
| May 12, 2020 | Rs. 5.00 | 2.03% |
| Apr 15, 2019 | Rs. 5.00 | 1.71% |
| Mar 21, 2018 | Rs. 5.00 | 1.11% |
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
M/s KPMG Taseer Hadi & Co. Chartered Accountants
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
December
Chief Executive Officer
Qawi Naseer
Chairperson
Farhan Muhammad Haroon
Company Secretary
Mashal Mohammad
Board of Directors
